Company / SG&A Expense
NEUROONE MEDICAL TECHNOLOGIES Corp SG&A Expense History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$7.9M
FY2025
5-year range
$4.8M / $7.9M
FY2021-FY2025
Trend
+14.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 10 years, ranging from $7,211 in FY2011 to $8M in FY2025.
Based on SEC 10-K filings.
$8M in FY2025 with a 10-year CAGR of +71.1%.
Increased from $7M to $8M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- +71.1%
Key checks
Key Insights
- 3-year CAGR of +8.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 14.1% year-over-year.
- Lowest sg&a expense in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.9M | +14.1% |
| FY2024 | $6.9M | -0.8% |
| FY2023 | $7.0M | +11.5% |
| FY2022 | $6.3M | +31.7% |
| FY2021 | $4.8M | +15274.5% |
| FY2016 | $30.9K | -15.7% |
| FY2015 | $36.7K | +39.3% |
| FY2014 | $26.3K | -14.2% |
| FY2012 | $30.7K | +325.6% |
| FY2011 | $7.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026